6/11/2021  9:59:54 PM Chg. -4.26 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
289.44USD -1.45% 7,914
Turnover: 2.29 mill.
-Bid Size: - -Ask Size: - 3.4 bill.USD 1.17% 43.73

Business description

Medifast (NYSE: MED) is the leading easy-to-use, clinically proven provider of weight-loss and healthy living products and programs. Medifast aims to help customers lead a healthier lifestyle through a holistic approach to weight-loss and weight management, nutrition education and fitness. Medifast's proven results are based on the use of structured meal plans featuring Medifast Meals, which are nutritionally designed to assist customers with successful weight-loss and weight management. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) the Take Shape For Life personal coaching division, 3) Medifast Weight Control Centers, and 4) a national network of physicians. The company also offers sports nutrition products under the brand Dual Fuel™ Nutrition that are formulated to provide athletes and active individuals with the right balance of carbohydrates and high quality protein for top performance. Medifast was founded in 1980 and is located in Owings Mills, Maryland.
 

Management board & Supervisory board

CEO
Daniel Chard
Management board
James Maloney, Bill Baker, Claudia Greninger, Jason L. Groves, Esq., Lauren Walker, Nicholas Johnson, Tony Tyree
Supervisory board
Andrea B. Thomas, Constance J. Hallquist, Daniel R. Chard, Jeffrey J. Brown, Kevin G. Byrnes, Michael A. Hoer, Scott Schlackman, Xian Ming
 

Company data

Name: Medifast Inc.
Address: 100 International Drive,Baltimore, Maryland 21202, USA
Phone: +1-410-581-8042
Fax: -
E-mail: -
Internet: www.medifast1.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 65.90%
IPO date: -

Investor relations

Name: Katie Turner
IR phone: +1-646-277-1228
IR Fax: -
IR e-mail: -

Main Shareholders

Freefloat
 
65.90%
BlackRock, Inc.
 
14.70%
The Vanguard Group
 
10.70%
Renaissance Funds
 
8.70%